Foster Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Foster Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$174K	Sell	13,816 -2,077	-13%	-$25.7K	﹤0.01%	304
2026 Q2	$230K	Sell	15,893 -6,702	-30%	-$90.4K	0.01%	287
2026 Q1	$313K	Buy	22,595 +5,892	+35%	+$82K	0.01%	209
2025 Q4	$235K	Sell	16,703 -7,405	-31%	-$104K	0.01%	256
2025 Q3	$337K	Buy	24,108 +1,435	+6%	+$20.6K	0.01%	189
2025 Q2	$341K	Buy	22,673 +7,835	+53%	+$112K	0.01%	175
2025 Q1	$196K	Buy	14,838 +1,134	+8%	+$15.6K	0.01%	216
2024 Q4	$216K	Buy	+13,704	New	+$206K	0.01%	183

Other funds holding RDY

Frank Rimerman Advisors Palo Alto, California $1.81B AUM 32.96% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

HCA

Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return

Hanson & Doremus Investment Management Burlington, Vermont $982M AUM 23.83% 1-Year Est. Return

AAM

Augustine Asset Management Jacksonville, Florida $464M AUM 16.89% 1-Year Est. Return

Dynamic Advisor Solutions Phoenix, Arizona $3.52B AUM 15.33% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Foster Group's RDY Position: Q3 2026 in Review

Foster Group reduced its Dr. Reddy's Laboratories (RDY) stake by 13% in Q3 2026, selling an estimated $25.7K and leaving 13,816 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

Foster Group first reported a position in RDY in Q4 2024 and has held it in 8 quarters since. The position peaked at $341K in Q2 2025. 22 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

Foster Group held 13,816 shares of Dr. Reddy's Laboratories worth $174K as of Q3 2026.
Foster Group sold 2,077 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $25.7K.
Dr. Reddy's Laboratories made up ﹤0.01% of Foster Group's portfolio in Q3 2026, its #304 holding.
Foster Group first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 8 quarters since.
Foster Group's Dr. Reddy's Laboratories position peaked at $341K in Q2 2025.
22 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.